Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Different Doses of Midazolam for 24-Hour Continuous Sedation in Pre-Eclamptic Women Undergoing Cesarean Section

NCT07021521 is registered in ClinicalTrials.gov with Zhuji People's Hospital of Zhejiang Province as lead sponsor.

NCT NCT07021521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07021521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Different Doses of Midazolam for 24-Hour Continuous Sedation in Pre-Eclamptic Women Undergoing Cesarean Section
Lead sponsor
Zhuji People's Hospital of Zhejiang Province
Phase
Not applicable
Overall status
Completed
Start date
April 5, 2021
Completion date
April 26, 2023
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section, efficacy, midazolam, pre-eclampsia, safety